Spots Global Cancer Trial Database for Feasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Feasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically

Official Title: Feasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically

Study ID: NCT06192771

Conditions

Dysphagia

Head and Neck Cancer

Interventions

ESSI-SURG

Standard-of-Care

Study Description

Brief Summary: Oral cavity cancer (OCC) is one of the most common cancers worldwide, with tongue cancer being one of the most common subtypes. Patients with oral cancers can experience painful swallowing, swallowing difficulty (dysphagia), and associated weight loss long after surgery. Not only is dysphagia an independent predictor of quality of life (QoL) in cancer survivorship, it can also have a devastating impact on the health of patients resulting from complications such as pneumonia, malnutrition and feeding tube dependence. Emerging evidence suggests that patients undergoing surgery benefit from engaging with speech-language pathologists (SLPs) before problems arise, to learn swallow strategies that may become useful in their rehabilitation. This in turn has the potential to reduce complications and minimize the length of feeding tube dependency. This study will assess the feasibility of conducting a prospective clinical trial that would evaluate the effects on patient health, function and overall benefit of early and systematic SLP speech and swallowing intervention for head and neck cancer patients planned for curative surgical treatment. We will also assess long-term changes in select clinical and patient-reported outcomes comparing their status before, and one month after, treatment.

Detailed Description: